Showing results (2031-2040 of 3,796) with videos related to

Sort By:
Pageof 380
Oncoimmunology|November 23, 2020
TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancerRalph Ja Maas, Janneke S Hoogstad-van Evert, Jolien Mr Van der Meer, et al.
Oncoimmunology|September 16, 2020
MMP2 as an independent prognostic stratifier in oral cavity cancersCaroline Hoffmann, Sophie Vacher, Philémon Sirven, et al.
Oncoimmunology|September 16, 2020
Standard therapies: solutions for improving therapeutic effects of immune checkpoint inhibitors on colorectal cancerTingting Liang, Weihua Tong, Siyang Ma, et al.
Oncoimmunology|September 16, 2020
Current Clinical Evidence and Potential Solutions to Increase Benefit of CAR T-Cell Therapy for Patients with Solid TumorsMarion Alcantara, Pauline Du Rusquec, Emanuela Romano
Oncoimmunology|September 16, 2020
Trial watch: STING agonists in cancer therapyJulie Le Naour, Laurence Zitvogel, Lorenzo Galluzzi, et al.
Oncoimmunology|September 16, 2020
SOD3 boosts T cell infiltration by normalizing the tumor endothelium and inducing laminin-α4Lorena Carmona-Rodríguez, Diego Martínez-Rey, Emilia Mira, et al.
Oncoimmunology|September 16, 2020
The consensus Immunoscore in phase 3 clinical trial (N0147) and impact on patient management decisionsAnastasia Lanzi, F A Sinicrope, A B Benson, et al.
Oncoimmunology|September 17, 2020
An integrated classifier improves prognostic accuracy in non-metastatic gastric cancerXiaofang Xing, Shuqin Jia, Yuxin Leng, et al.
Oncoimmunology|September 17, 2020
Primary and metastatic breast tumors cross-talk to influence immunotherapy responsesAmanda J Oliver, Simon P Keam, Bianca von Scheidt, et al.
Oncoimmunology|September 17, 2020
Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysisBaihui Li, Bailu Zhang, Xuezhou Wang, et al.
Pageof 380